Ohio Public Employees Retirement System (OPERS)’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
BG
WA
MC
RG
Ohio Public Employees Retirement System (OPERS)'s ATRA Position: Q3 2023 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 7,543 shares — an estimated $304K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in ATRA in Q4 2018 and held it in 17 quarters. The position peaked at $1.63M in Q3 2021. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 7,543 Atara Biotherapeutics shares in Q3 2023, an estimated $304K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Atara Biotherapeutics in Q4 2018 and held it in 17 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Atara Biotherapeutics position peaked at $1.63M in Q3 2021.
- 109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2023, filed 15 Nov 2023.